If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1989 Doctorate of Medical Science, Research Institute of Clinical Medicine, National Defense Medical Center, Taipei, Taiwan
  • 1983 Bachelor of Medicine, National Defense Medical Center, Taipei, Taiwan

Experience

  • Director, Division of Oncology, Department of internal Medicine, College of Medicine, Taipei Medical University
  • 2018.02- Professor, International Master/Ph.D Program in Medicine, College of Medicine, Taipei Medical University
  • 2016.11-2017.10 Professor, International Master/Ph.D Program in Medicine, College of Medicine, Taipei Medical University
  • 2010.10- Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
  • 2015.10-2019.07.31 Deputy Director, Department of Human Research, Taipei Medical University
  • 2015.02- Chief, Department of Medical Affairs, Shuang Ho Hospital, Taipei Medical University
  • 2014.02-2015.09 Director, Joint Clinical Research Center, Taipei Medical University
  • 2010.10- Chief and Professor, Division of Hematology/Oncology, Shuang-Ho Hospital, Taipei Medical University,
  • 2010.10-2015.01 Chief and Professor, Division of Internal Medicine, Shuang-Ho Hospital, Taipei Medical University, Taipei, Taiwan
  • 1997.05-2010.09 Chief and Professor, Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan,
  • 1992.09-1997.06 Attending Physician, Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan,
  • 1987-1789 Research Fellow, Department of Immunology and Biochemistry Research, Roswell Park Memorial Institute,
  • 1983-1992 Resident, Chief Resident, Fellow, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Awards

  • 2008 The best 100 physicians of Taiwan
  • 2005 Teacher of the year, National Defense University
  • 2001 Remarkable physician of Tri-Service General Hospital
  • 2000 Teacher of the year, National Defense Medical Center. September
  • 1998 Decent Man, Tri-Service General Hospital
  • 1997 International Who's Who of Contemporary Achievement, Hall of Fame, awarded by the American Biographical Institute
  • 1996 Men of Achievement, 17th edition, published by The International Biographical Center, Cambridge, England
  • 1994 Outstanding Military Physician honored by the Ministry of Defense, Taiwan, R. O. C.
  • 1994-1995 Scholarship of Biomedical Science for physician awarded by Academia Sinica, Taiwan, R. O. C.
  • 1993 Distinguished Youth of Taipei City
  • 1992 Remarkable physician of Tri-Service General Hospital
  • 1989 First class Academic Medal, awarded by Ministry of Defense, R. O. C.
  • 1983 Second class Academic Medal, awarded by Ministry of Defense, R. O. C.

Research Interests

  • Dr. Chao’s current researchinterests focus on clinical trials and translational studies. The clinical trials he involves are about the development of new drugs or strategies in treating cancers and hematological disorders. In translational studies, his major effort is on the development of a novel biochemical marker, i.e. tartrate-resistant acid phosphatase 5b, in the diagnosis and monitoring of metastatic bone disease of breast cancer. He also intends to define the role and search the potential usefulness of tartrate-resistant acid phosphatase 5a in macrophage-related disorders.

Fingerprint Dive into the research topics where Tsu-Yi Chao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Serum Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2017

Research Output 1989 2019

  • 4220 Citations
  • 26 h-Index
  • 195 Article
  • 1 Letter
  • 1 Review article

An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma

El Dika, I., Lim, H. Y., Yong, W. P., Lin, C. C., Yoon, J. H., Modiano, M., Freilich, B., Choi, H. J., Chao, T. Y., Kelley, R. K., Brown, J., Knox, J., Ryoo, B. Y., Yau, T. & Abou-Alfa, G. K., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access
Maximum Tolerated Dose
Hepatocellular Carcinoma
Pharmacokinetics
Safety
Small Interfering RNA

Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling

Chen, J. H., T.H Wu, A., T.W Tzeng, D., Huang, C. C., Tzeng, Y. M. & Chao, T. Y., Jan 1 2019, In : Phytomedicine. 52, p. 70-78 9 p.

Research output: Contribution to journalArticle

Antrodia
Catenins
Carcinogenesis
Breast
Down-Regulation
Triple Negative Breast Neoplasms
Catenins
Neoplastic Stem Cells
Down-Regulation
Phenotype

Chemotherapy agents induce tartrate-resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients

Chou, H. L., Chao, T. Y., Chen, T. C., Chu, C. M., Hsieh, C. H., Lin, L. I. & Yao, C. T., Mar 5 2019, In : European Journal of Pharmacology. p. 38-48 11 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Drug Therapy
Monocytes
Macrophages
gemcitabine